Chapter 152 Development of a Manufacturing Process for the Formation of a Nucleoside Drug Candidate

Chapter 166 Development of Efficient Routes to Access C -Glycosides as SGLT-2 Inhibitors for the Treatment of Type 2 Diabetes

Chapter 183 Synthetic Routes to Sofosbuvir

Chapter 184 Synthetic Challenges in the Assembly of Macrocyclic HCV NS3/NS4A Protease Inhibitors: The Case of BILN 2061 and Its Analogs

Chapter 189 Recent Progress in the Synthesis of Super-Statins

Chapter 200 Development of Synthetic Routes to Dolutegravir

Chapter 201 Story of Eribulin Mesylate: Development of the Longest Drug Synthesis